Fig. 2

Sensitivity (panel A) and specificity (panel B) of serum intestinal fatty acid-binding protein (I-FABP) predicting AMI. AMI—acute mesenteric ischaemia; NOMI—non-occlusive mesenteric ischaemia; SBO—strangulated bowel disease. Any stage—studies assessing different stages of AMI, including but not limited to non-transmural and transmural; Transmural—studies assessing transmural AMI, with control group including non-transmural AMI. Comment: Uzun 2014 included healthy volunteers as control. Hycult—Hycult Biotech measurement kit from Uden, the Netherlands. Osaka—D.S. Pharma Biomedical measurement kit from Osaka, Japan. R&D—R&D Systems measurement kit from Minneapolis, USA